RespireRx Pharmaceuticals Inc.: A Biopharmaceutical Company Email Format

Biotechnology ResearchNew Jersey, United States2-10 Employees

RespireRx Pharmaceuticals Inc. is a small biopharmaceutical company based in Glen Rock, New Jersey, that develops medicines for psychiatric and neurological disorders where treatment options are limited. Its pipeline rests on two drug platforms: pharmaceutical cannabinoids, including a synthetic form of THC for obstructive sleep apnea, a condition affecting an estimated 29.4 million people in the United States, and neuromodulators such as AMPAkines and GABAkines aimed at CNS-driven conditions like ADHD, epilepsy, chronic pain, and spinal cord injury recovery. In Phase 2 studies, dronabinol yielded statistically significant improvements in obstructive sleep apnea, and a lead ampakine produced rapid, statistically significant improvement in adult ADHD.

The company serves patients affected by sleep and neurological disorders and positions itself within the biotechnology research sector, leveraging broad patent protection across its two drug platforms. In January 2024, RespireRx announced the appointment of Dr. Dariusz Nasiek to its board, reflecting ongoing governance development.

Get verified RespireRx Pharmaceuticals Inc.: A Biopharmaceutical Company emails free

Company overview Employee directory